Production (Stage)
Heron Therapeutics, Inc.
HRTX
$2.12
$0.000.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -29.14% | -26.27% | -8.43% | 102.58% | 19.16% |
| Total Receivables | 20.54% | 31.17% | 5.09% | -3.89% | 26.97% |
| Inventory | 34.04% | 26.24% | 9.39% | -3.94% | -18.41% |
| Prepaid Expenses | 302.40% | 189.15% | 5.04% | -32.38% | -55.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 14.49% | 10.72% | 0.62% | 15.66% | 4.35% |
|
|
|||||
| Total Current Assets | 14.49% | 10.72% | 0.62% | 15.66% | 4.35% |
| Net Property, Plant & Equipment | -31.00% | -31.07% | -29.68% | -26.76% | -15.68% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -20.31% | -20.24% | -19.83% | -19.26% | -44.23% |
| Total Assets | 8.20% | 4.78% | -3.67% | 8.40% | -1.35% |
|
|
|||||
| Total Accounts Payable | 1,373.48% | 261.39% | 447.74% | 422.53% | -79.41% |
| Total Accrued Expenses | 113.17% | 4.55% | -47.11% | -61.73% | -51.52% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -27.00% | -1.24% | 8.34% | 23.80% | 13.58% |
| Total Finance Division Other Current Liabilities | -89.24% | -- | 673.97% | 799.76% | 985.68% |
| Total Other Current Liabilities | -89.24% | -- | 673.97% | 799.76% | 985.68% |
| Total Current Liabilities | 17.48% | 14.77% | 7.27% | -7.39% | -3.24% |
|
|
|||||
| Total Current Liabilities | 17.48% | 14.77% | 7.27% | -7.39% | -3.24% |
| Long-Term Debt | 0.56% | 0.56% | 0.58% | 16.63% | 16.51% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -85.24% | -69.00% | -57.67% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 182.99% | 155.19% | 0.00% | 0.00% | 0.00% |
| Total Liabilities | 4.99% | 4.02% | 1.48% | 6.47% | 8.33% |
|
|
|||||
| Common Stock & APIC | 0.70% | 0.74% | 0.84% | 2.70% | 3.23% |
| Retained Earnings | -0.41% | -0.71% | -1.48% | -2.57% | -4.43% |
| Treasury Stock & Other | 116.67% | 0.00% | 4,100.00% | -33.33% | -166.67% |
| Total Common Equity | 15.73% | 0.95% | -43.98% | 3.42% | -195.44% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 15.73% | 0.95% | -43.98% | 3.42% | -195.44% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 15.73% | 0.95% | -43.98% | 3.42% | -195.44% |
|
|
|||||